SuperworthLifeward EPS LFWD
Diluted earnings per share by quarter and over the last twelve months, from 2015.
- Last 12 months, to Jun 30, 2026
- −$16.82
- Latest quarter, Q2 FY26
- −$4.12
- Fiscal year 2025
- −$18.54
Lifeward's earnings per share was −$16.82 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$4.12.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$18.54 | n/a |
| FY2024 | −$39.72 | n/a |
| FY2023 | −$31.08 | n/a |
| FY2022 | −$26.88 | n/a |
| FY2021 | −$22.68 | n/a |
| FY2020 | −$76.44 | n/a |
| FY2019 | −$259.56 | n/a |
| FY2018 | −$1296.96 | n/a |
| FY2017 | −$2667.00 | n/a |
| FY2016 | −$5208.00 | n/a |
| FY2015 | −$4431.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$4.12 | n/a | −$16.82 | |
| Q1 FY26 | −$6.70 | n/a | −$19.71 | |
| Q4 FY25 | −$3.60 | n/a | −$18.54 | |
| Q3 FY25 | −$2.40 | n/a | −$35.70 | |
| Q2 FY25 | −$7.01 | n/a | −$37.50 | |
| Q1 FY25 | −$5.53 | n/a | −$36.49 | |
| Q4 FY24 | −$20.76 | n/a | −$39.72 | |
| Q3 FY24 | −$4.20 | n/a | −$26.76 | |
| Q2 FY24 | −$6.00 | n/a | −$33.12 | |
| Q1 FY24 | −$8.76 | n/a | −$33.72 | |
| Q4 FY23 | −$7.80 | n/a | −$31.08 | |
| Q3 FY23 | −$10.56 | n/a | −$30.84 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Lifeward's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| LFWDLifeward | −$16.82 | |
| NEPHNephros | $0.16 | +33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| Peer median | $0.41 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Lifeward
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.